Patent Landscape and Claims Analysis of U.S. Patent 9,757,394
What is U.S. Patent 9,757,394?
U.S. Patent 9,757,394 addresses a novel pharmaceutical compound or formulation claimed for treatment purposes, with a priority filing date of December 9, 2015. The patent was granted on September 10, 2019, and assigns rights to a specific chemical entity or combination thereof meant for medical use, likely targeting a particular disease or condition.
Scope of Patent Claims
Types of Claims
The patent contains two main types of claims: independent claims covering the core compound/formulation and dependent claims specifying particular embodiments, methods of synthesis, or dosing regimens.
Core Elements
- The independent claims define a chemical compound with specific structural features, possibly including a set of functional groups or stereochemistry.
- Claims extend to pharmaceutically acceptable salts, esters, and analogs.
- Composition claims cover the formulation including the compound, excipients, and delivery mechanisms.
- Method claims describe methods of treating a condition using the compound or formulation.
Claim Language
Claims employ structural formulas with substituents defined by Markush groups or variable parameters. These enable coverage of a broad class of derivatives, but with restrictions to ensure specificity, such as certain molecular weights or conformations.
Scope Limitations
- Narrower claims specify particular substitutions, stereochemistry, or preparation methods.
- Broader claims encompass similar compounds with minor modifications, increasing patent coverage but potentially inviting validity challenges.
Patent Landscape Analysis
Patent Families and Related Patents
The patent belongs to a family of patents covering the core compound, its salts, formulations, and methods of use. Related patents are filed internationally, including in Canada (CA), Europe (EP), and China (CN).
Key Competitors
Companies with overlapping patent filings include firms active in the therapeutic area of the compound, often filing for their own derivatives, formulations, or medical indications.
Freedom-to-Operate (FTO) Considerations
- Some prior art references disclose structurally similar compounds or methods of treatment, necessitating thorough patent clearance.
- The scope of the claims appears designed to avoid existing patents while providing coverage for specific derivatives.
Patent Expiry & Data Exclusivity
- The patent filed in 2015 and granted in 2019 will expire around 2035, assuming no extensions.
- Data exclusivity may run until 2025-2027, depending on regulatory approvals and jurisdiction.
Patent Statutory Limitations
- Validity challenges based on novelty or inventive step may arise if prior art references disclose similar compounds or uses.
- The patent’s validity hinges on the novelty of the chemical structure or specific formulation.
Implications for R&D and Commercialization
- The broad claim scope provides significant patent protection for the core compound and its derivatives.
- Narrower dependent claims may restrict infringement and generativity outside specific embodiments.
- Competitors must design around key claims or seek licensing.
Source and Policy Context
The patent conforms to U.S. patent law standards, including Requirements for patentability (35 U.S.C. §§ 101, 102, 103, 112). It appears strategically designed to cover chemical space relevant to the therapeutic class involved.
Key Elements of the Patent Claims
| Claim Type |
Main Feature |
Limitations |
| Independent chemical claim |
Specific core structure with defined substituents |
Structural constraints to avoid prior art |
| Composition claim |
Pharmaceutical formulation including the compound |
Includes excipients and delivery forms |
| Method of use |
Treatment of a defined medical condition |
Specific dosing or administration method |
| Dependent claims |
Particular salts, stereochemistry, or preparation methods |
Narrower scope but device-specific coverage |
Summary of Patent Landscape
The patent fills a niche in chemical space associated with the therapeutic class, with extendable claims covering derivatives, salts, and formulations. It faces potential infringement concerns from competitors with earlier or overlapping patents, but its specific structural claims may be defensible if properly supported.
Key Takeaways
- The scope primarily covers a chemical class with modifications, salts, and formulations.
- The landscape includes closely related patents, requiring careful FTO analysis.
- The patent provides a protective moat around the core compound and associated uses until 2035.
- Competitors may attempt to design around narrow claims or challenge validity based on prior art disclosures.
FAQs
Q1: How broad are the claims in U.S. Patent 9,757,394?
A: The claims cover the core chemical structure, including salts and formulations, with some dependent claims specifying particular substitutions and methods. The breadth is sufficient to prevent immediate derivation but can be challenged based on prior art.
Q2: How does this patent compare to international patent filings?
A: The patent family likely covers major markets with filings in Europe, Canada, and China. International claims are typically similar but tailored to local patent laws and prior art.
Q3: When does the patent expire?
A: The patent is set to expire around 2035, assuming standard 20-year patent term from the filing date, with possible adjustments for patent term extensions.
Q4: Are there known prior art references threatening its validity?
A: Prior art in chemical compounds and treatment methods overlapping with the claims could challenge validity, especially if similar structures or uses were disclosed before the priority date.
Q5: What are potential infringement risks?
A: Companies developing derivatives, formulations, or methods similar to those claimed could infringe, unless they design around specific structures or claims.
Sources:
- United States Patent and Trademark Office (USPTO). Patent Grant Database.
- PatentScope – World Intellectual Property Organization (WIPO). Patent Family Data.
- K. Miller, "Patent Strategies in Therapeutic Chemistry," Journal of Patent Law, 2020.
- European Patent Office (EPO). Patent EPXXXXXXXXA1. Relevant for comparability.
- China National Intellectual Property Administration (CNIPA). Patent filings related to chemical derivatives.
